0001209191-19-022709.txt : 20190402
0001209191-19-022709.hdr.sgml : 20190402
20190402184910
ACCESSION NUMBER: 0001209191-19-022709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190402
DATE AS OF CHANGE: 20190402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LUDLAM WILLIAM
CENTRAL INDEX KEY: 0001736280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37500
FILM NUMBER: 19726796
MAIL ADDRESS:
STREET 1: C/O CHIASMA, INC.
STREET 2: 460 TOTTEN POND ROAD, SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIASMA, INC
CENTRAL INDEX KEY: 0001339469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 460 TOTTEN POND ROAD
STREET 2: SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-928-5300
MAIL ADDRESS:
STREET 1: 460 TOTTEN POND ROAD
STREET 2: SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: CHIASMA INC
DATE OF NAME CHANGE: 20050922
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-01
0
0001339469
CHIASMA, INC
CHMA
0001736280
LUDLAM WILLIAM
C/O CHIASMA, INC.
460 TOTTEN POND ROAD SUITE 530
WALTHAM
MA
02451
0
1
0
0
See Remarks
Common Stock
2019-04-01
4
P
0
1625
5.00
A
6749
D
The purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Title: Senior Vice President, Clinical and Medical Affairs
/s/ Mark Fitzpatrick, Attorney-In-Fact
2019-04-02